5pvs: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==PanDDA analysis group deposition -- Crystal Structure of BRD1 after initial refinement with no ligand modelled (structure 243)== | ==PanDDA analysis group deposition -- Crystal Structure of BRD1 after initial refinement with no ligand modelled (structure 243)== | ||
<StructureSection load='5pvs' size='340' side='right' caption='[[5pvs]], [[Resolution|resolution]] 1.55Å' scene=''> | <StructureSection load='5pvs' size='340' side='right'caption='[[5pvs]], [[Resolution|resolution]] 1.55Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5pvs]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[5pvs]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5PVS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5PVS FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.55Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5pvs FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5pvs OCA], [https://pdbe.org/5pvs PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5pvs RCSB], [https://www.ebi.ac.uk/pdbsum/5pvs PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5pvs ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/BRD1_HUMAN BRD1_HUMAN] Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.<ref>PMID:16387653</ref> <ref>PMID:21880731</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5pvs" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5pvs" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Bromodomain-containing protein 3D structures|Bromodomain-containing protein 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Arrowsmith | [[Category: Large Structures]] | ||
[[Category: Bountra | [[Category: Arrowsmith CH]] | ||
[[Category: Bradley | [[Category: Bountra C]] | ||
[[Category: Brandao-Neto | [[Category: Bradley AR]] | ||
[[Category: Brennan | [[Category: Brandao-Neto J]] | ||
[[Category: Collins | [[Category: Brennan PE]] | ||
[[Category: Cox | [[Category: Collins P]] | ||
[[Category: Cox O]] | |||
[[Category: Dias | [[Category: Dias A]] | ||
[[Category: Douangamath | [[Category: Douangamath A]] | ||
[[Category: Edwards | [[Category: Edwards A]] | ||
[[Category: Fairhead | [[Category: Fairhead M]] | ||
[[Category: Krojer | [[Category: Krojer T]] | ||
[[Category: MacLean | [[Category: MacLean E]] | ||
[[Category: Ng | [[Category: Ng J]] | ||
[[Category: Pearce | [[Category: Pearce NM]] | ||
[[Category: Renjie | [[Category: Renjie Z]] | ||
[[Category: Sethi | [[Category: Sethi R]] | ||
[[Category: Talon | [[Category: Talon R]] | ||
[[Category: Wright | [[Category: Wright N]] | ||
[[Category: | [[Category: Von Delft F]] | ||
Revision as of 17:21, 24 January 2024
PanDDA analysis group deposition -- Crystal Structure of BRD1 after initial refinement with no ligand modelled (structure 243)PanDDA analysis group deposition -- Crystal Structure of BRD1 after initial refinement with no ligand modelled (structure 243)
Structural highlights
FunctionBRD1_HUMAN Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.[1] [2] Publication Abstract from PubMedIn macromolecular crystallography, the rigorous detection of changed states (for example, ligand binding) is difficult unless signal is strong. Ambiguous ('weak' or 'noisy') density is experimentally common, since molecular states are generally only fractionally present in the crystal. Existing methodologies focus on generating maximally accurate maps whereby minor states become discernible; in practice, such map interpretation is disappointingly subjective, time-consuming and methodologically unsound. Here we report the PanDDA method, which automatically reveals clear electron density for the changed state-even from inaccurate maps-by subtracting a proportion of the confounding 'ground state'; changed states are objectively identified from statistical analysis of density distributions. The method is completely general, implying new best practice for all changed-state studies, including the routine collection of multiple ground-state crystals. More generally, these results demonstrate: the incompleteness of atomic models; that single data sets contain insufficient information to model them fully; and that accuracy requires further map-deconvolution approaches. A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.,Pearce NM, Krojer T, Bradley AR, Collins P, Nowak RP, Talon R, Marsden BD, Kelm S, Shi J, Deane CM, von Delft F Nat Commun. 2017 Apr 24;8:15123. doi: 10.1038/ncomms15123. PMID:28436492[3] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||